Where is Kuur Therapeutics headquartered?

Kuur Therapeutics is located in Houston, TX.

Who invested in Kuur Therapeutics?

Kuur Therapeutics has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Kuur Therapeutics raised to date?

Kuur Therapeutics has raised ____.

When was the last funding round for Kuur Therapeutics?

Kuur Therapeutics closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

kuurtx.com

Kuur Therapeutics

Kuur is a Texas-based biopharmaceutical company that researches and develops CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies.

Business Model:

Revenue: $3.2M

Employees: 51-200

Rankings

Industries / Tags:

Pharmaceuticals & Biotechnology

Biotechnology

Health Care

Medical

Detailed Kuur Therapeutics Information

M&A Details

Kuur Therapeutics was acquired by Athenex.
The acquisition happend on 2021-05-04.
Details of the transaction were not public

Acquirer

Athenex

General Information

Geographic Data

Address: 2617 Bissonnet Street

City: Houston

State: TX

Zip: 77005

Country: US

Financial Info

Stage:

secondary market

Raised Last:

$0

Raised Total:

$192M

Social

Facebook

Twitter

Crunchbase

Metrics

6,899,436Website Global Rank

1,146Website Monthly Traffic

Twitter Followers

Description

Kuur is a Texas-based biopharmaceutical company that researches and develops CAR-NKT cell immunotherapies for the treatment of solid and hematological malignancies.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2019	Grant		$8.7M
3/2017	Series C		$73.2M	Touchstone Innovations plc Invesco Asset Managemen woodford Investment Management
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.
7/2012	Equity		$26.4M	The Wellcome Trust Imperial Innovations
3/2020	Equity		-
12/2009	Grant		$2.2M
11/2014	Series B		$78.3M	Imperial Innovations Invesco Perpetual Woodford Investment Management
3/2017	Series C	3	$73.7M	Invesco Perpetual Touchstone Innovations Woodford Investment Management Touchstone Innovations Invesco Perpetual Touchstone Innovations Woodford Investment Management Touchstone Innovations
7/2012	Venture Round	3	$26.4M	Wellcome Trust Invesco Imperial Innovations Wellcome Trust Invesco Imperial Innovations
11/2014	Series B	3	$78.5M	Imperial Innovations Invesco Woodford Investment Management Imperial Innovations Invesco Woodford Investment Management
9/2009	Venture Round	1	$7.3M	Imperial Innovations Imperial Innovations
3/2007	Venture Round	2	$3.7M	Wellcome Trust Innovations New Ventures
3/2020	Equity		-	IP Group Baylor College of Medicine Schroeder Adveq IP Group Baylor College of Medicine Schroeder Adveq
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.

Acquisitions

Announced Date	Name	Price
6/2017	CGT Catapult
7/2016	Delenex Therapeutics

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details